DrugPatentWatch Database Preview

Rucaparib camsylate - Generic Drug Details

What are the generic drug sources for rucaparib camsylate and what is the scope of rucaparib camsylate patent protection?

Rucaparib camsylate is the generic ingredient in one branded drug marketed by Clovis Oncology Inc and is included in one NDA. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Rucaparib camsylate has two hundred and thirty-six patent family members in fifty-two countries.

One supplier is listed for this compound.

Summary for rucaparib camsylate

International Patents:	236
US Patents:	10
Tradenames:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	12
Clinical Trials:	4
Patent Applications:	2
DailyMed Link:	rucaparib camsylate at DailyMed

Pharmacology for rucaparib camsylate

Drug Class	Poly(ADP-Ribose) Polymerase Inhibitor
Mechanism of Action	Poly(ADP-Ribose) Polymerase Inhibitors

US Patents and Regulatory Information for rucaparib camsylate

+ Get email alerts for changes to this table

Glossary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Clovis Oncology Inc	RUBRACA	rucaparib camsylate	TABLET;ORAL	209115-003	May 1, 2017		RX	Yes	No	➤ Try a Free Trial	➤ Try a Free Trial	Y	Y		➤ Try a Free Trial
Clovis Oncology Inc	RUBRACA	rucaparib camsylate	TABLET;ORAL	209115-003	May 1, 2017		RX	Yes	No	➤ Try a Free Trial	➤ Try a Free Trial				➤ Try a Free Trial
Clovis Oncology Inc	RUBRACA	rucaparib camsylate	TABLET;ORAL	209115-001	Dec 19, 2016		RX	Yes	No	➤ Try a Free Trial	➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

International Patents for rucaparib camsylate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration
Brazil	PI0412909	➤ Try a Free Trial
South Korea	20060123403	➤ Try a Free Trial
Hungary	E025996	➤ Try a Free Trial
Country	Patent Number	Estimated Expiration

Supplementary Protection Certificates for rucaparib camsylate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1633724	2015/016	Ireland	➤ Try a Free Trial	PRODUCT NAME: OLAPARIB, AND SALTS AND SOLVATES THEREOF; REGISTRATION NO/DATE: EU/1/14/959/001 20141216
1633724	S1500012	Hungary	➤ Try a Free Trial	PRODUCT NAME: OLAPARIB
1633724	C300726	Netherlands	➤ Try a Free Trial	PRODUCT NAME: OLAPARIB, EN ZOUTEN EN; REGISTRATION NO/DATE: EU/1/14/959/001 20141216
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description